Sean Brynjelsen - Jul 12, 2022 Form 4 Insider Report for Eton Pharmaceuticals, Inc. (ETON)

Role
Chief Executive Officer
Signature
/s/ Sean E. Brynjelsen
Stock symbol
ETON
Transactions as of
Jul 12, 2022
Transactions value $
$0
Form type
4
Date filed
7/18/2022, 04:36 PM
Previous filing
Feb 28, 2022
Next filing
Sep 23, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETON Restricted Stock Units Award $0 +110K $0.00 110K Jul 12, 2022 Common Stock 110K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock.
F2 The restricted stock units vest in four equal annual installments beginning July 12, 2023, contingent upon the reporting person being employed by the issuer on the date(s) of vesting.